Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.03. | Infant Bacterial Therapeutics: IBT is granted Breakthrough Therapy Designation for its Drug Candidate | 20 | GlobeNewswire (Europe) | The U.S. Food and Drug Administration (FDA) has granted a Breakthrough Therapy designation for IBP-9414's potential to reduce gastrointestinal-related mortality. A breakthrough designation is intended... ► Artikel lesen | |
28.03. | Premium Global Income Split Corp. Announces Year End Results | 101 | GlobeNewswire (Europe) | TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- (TSX: PGIC; PGIC.PR.A) Premium Global Income Split Corp. (the "Fund") announces results of operations for the year ended December 31, 2024. Increase in... ► Artikel lesen | |
28.03. | Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results | 3.712 | GlobeNewswire (Europe) | TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF (the "Fund") announces results of operations for the year ended December 31, 2024. Increase in net... ► Artikel lesen | |
28.03. | Callan JMB Inc.: Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update | 430 | GlobeNewswire (Europe) | Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option SPRING BRANCH, Texas, March 28... ► Artikel lesen | |
28.03. | WF Holding Limited Announces Closing of Initial Public Offering | 434 | GlobeNewswire (Europe) | KUALA LUMPUR, March 28, 2025 (GLOBE NEWSWIRE) -- WF Holding Limited ("WF Holding" or "Company"), a Malaysia-based manufacturer of fiberglass reinforced plastic (FRP) products, announced today the... ► Artikel lesen | |
28.03. | HilleVax, Inc.: HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress | 141 | GlobeNewswire (Europe) | $171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults... ► Artikel lesen | |
28.03. | Evome Medical Technologies Inc.: Evome Medical Technologies Provides Market Update | 109 | GlobeNewswire (Europe) | NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) is providing an update to shareholders today. As important background: Evome generates... ► Artikel lesen | |
28.03. | Mawson Infrastructure Group Inc. Reports Fiscal Year 2024 Financial Results | 161 | GlobeNewswire (Europe) | 136% Y/Y Revenue Growth in Digital Colocation Business 42% Y/Y Revenue Growth in Energy Management Business 35% Y/Y Increase in Overall Gross Profit Expanded into Artificial Intelligence (AI) and... ► Artikel lesen | |
28.03. | Traws Pharma, Inc.: Traws Pharma Announces Management Updates | 360 | GlobeNewswire (Europe) | Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim CEO NEWTOWN, Pa., March 28, 2025 (GLOBE NEWSWIRE) -- Traws... ► Artikel lesen | |
28.03. | Markforged Holding Corporation: Markforged Announces Fourth Quarter and Full Year 2024 Results | 153 | GlobeNewswire (Europe) | WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Markforged Holding Corporation (NYSE: MKFG) ("Markforged"), the company strengthening manufacturing resiliency by enabling industrial production... ► Artikel lesen | |
28.03. | Ambow Education Holding Ltd.: Ambow Education Announces Second Half and Full-Year 2024 Financial Results | 148 | GlobeNewswire (Europe) | CUPERTINO, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- Ambow Education Holding Ltd. (NYSE American: AMBO) ("Ambow" or the "Company"), an AI-driven educational technology company, today announced its... ► Artikel lesen | |
28.03. | Enzo Biochem, Inc.: Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX | 146 | GlobeNewswire (Europe) | FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company") today announced its intention to voluntarily delist its common stock from The New York... ► Artikel lesen | |
28.03. | FutureFuel Corp.: FutureFuel Releases 2024 Results | 1.630 | GlobeNewswire (Europe) | CLAYTON, Mo., March 28, 2025 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) ("FutureFuel"), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for... ► Artikel lesen | |
28.03. | Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | 114 | GlobeNewswire (Europe) | - Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer - - Positive Preliminary Phase 1b/2... ► Artikel lesen | |
28.03. | Sanofi: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors | 278 | GlobeNewswire (Europe) | Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first antithrombin-lowering therapy in hemophilia, offers consistent... ► Artikel lesen | |
28.03. | Pactiv Evergreen Inc. Announces Receipt of All Required Regulatory Approvals for Planned Acquisition by Novolex | 1.674 | GlobeNewswire (Europe) | LAKE FOREST, Ill., March 28, 2025 (GLOBE NEWSWIRE) -- Pactiv Evergreen Inc. ("Pactiv Evergreen" or the "Company") (NASDAQ: PTVE) today announced that all required regulatory approvals have been received... ► Artikel lesen | |
28.03. | Entera Bio Ltd.: Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates | 498 | GlobeNewswire (Europe) | JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and... ► Artikel lesen | |
28.03. | Foresight Autonomous Holdings Ltd.: Foresight Receives Nasdaq Notification Regarding Minimum Bid Requirements | 1.175 | GlobeNewswire (Europe) | Ness Ziona, Israel, March 28, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) ("Foresight" or the "Company"), an innovator in 3D perception systems, announced today... ► Artikel lesen | |
28.03. | Alector, Inc.: Alector Provides Executive Leadership Update | 221 | GlobeNewswire (Europe) | --Giacomo Salvadore, M.D., appointed Chief Medical Officer-- --Gary Romano, M.D., Ph.D., to transition from Chief Medical Officer role-- SOUTH SAN FRANCISCO, Calif., March 28, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
28.03. | Aimfinity Investment Corp. I Announces Approval by Shareholders of its Business Combination with Docter Inc. | 844 | GlobeNewswire (Europe) | Wilmington, DE, March 28, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the "AIMA") (Nasdaq: AIMAU), a special purpose acquisition company, today announced that, the previously announced... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 5.142 |
STEYR MOTORS | 2.900 |
RENK GROUP | 2.680 |
RHEINMETALL | 2.595 |
BYD | 2.109 |
DEUTZ | 1.928 |
TUI | 1.756 |
TESLA | 1.665 |
EVOTEC | 1.414 |
NEL | 1.217 |
APPLE | 1.164 |
ASML | 1.114 |
BASF | 983 |
DEUTSCHE BANK | 957 |
MERCEDES-BENZ | 942 |
NOVO NORDISK | 925 |
INFINEON | 917 |
BAYER | 875 |
PUMA | 875 |
VOLKSWAGEN | 868 |
XIAOMI | 866 |
THYSSENKRUPP | 865 |
LVMH | 858 |
ALLIANZ | 825 |
PLUG POWER | 815 |